InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: macnqueso post# 2556

Saturday, 12/28/2013 11:03:32 AM

Saturday, December 28, 2013 11:03:32 AM

Post# of 3756
IMOH...XXII is not a true biotech stock. Its a hybrid. It will have a basic "staples" business with or without FDA, which can flourish elsewhere (outside the U.S.) and quite handsomely.

The biotech aspect is the FDA designation as VLN...which is just a bonus.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.